HERON THERAPEUTICS, INC. /DE/ (HRTX) Free cash flow 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$27.9MFY2025 · since FY2016: -$137.2M → -$27.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.9M | -15.2% |
| FY2024 | -$24.2M | +59.8% |
| FY2023 | -$60.3M | +59.4% |
| FY2022 | -$148.7M | +27.9% |
| FY2021 | -$206.4M | -7.7% |
| FY2020 | -$191.6M | -45.5% |
| FY2019 | -$131.7M | +34.5% |
| FY2018 | -$201.0M | -16.3% |
| FY2017 | -$172.9M | -26.0% |
| FY2016 | -$137.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice